Whole body PD-1 and PD-L1 PET with Zr-89-nivolumab and F-18-BMS-986192 in pts with NSCLC.

Anna-Larissa N. Niemeijer, Egbert F. Smit, G. A. M. S. van Dongen, A. D. Windhorst, Marc C. Huisman, N. Harry Hendrikse, David K. Leung, Ralph Adam Smith, Wendy Hayes, Erik Thunnissen, Alex J. Poot, Danielle J. Vugts

Research output: Contribution to journalMeeting AbstractAcademicpeer-review

Original languageEnglish
JournalJournal of clinical oncology
Publication statusPublished - 20 May 2017

Cite this